Multi-Institutional Collaborative Cohort Study on the improvement of marker for diabetes mellitus and oral malodor by periodontal treatment (MICCS-DOP)
Not Applicable
- Conditions
- Diabetes Mellitus Periodontal Disease
- Registration Number
- JPRN-UMIN000010938
- Lead Sponsor
- Okayama University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
A) Patient with a serious liver disease or renal disease B) Patient with malignant tumor C) Poorly controlled diabetic patient (fasting blood sugar: over 160 mg/dl or HbA1c[NGSP]: over 8.4% ) D) Patient scheduled for surgery E) In addition, patient being deemed inappropriate as subject in this study by the dentist
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. test value for diabetes mellitus: HbA1c, LDL, HDL, TG, FBS 2. test value for periodontal desease: pocket depth, bleeding on probing, tooth mobility, IgG titer against periodontal pathogens, bone loss index 3. halitosis test level: bless checker level 4. Inflammatory marker: WBC, hs-CRP
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways link periodontal treatment to glycemic control in diabetes mellitus patients?
How does periodontal therapy compare to standard diabetes care in reducing HbA1c and oral malodor?
Which biomarkers predict response to periodontal intervention in diabetic patients with periodontitis?
What are the long-term adverse effects of non-surgical periodontal treatment in type 2 diabetes cohorts?
How do anti-inflammatory agents in periodontal care synergize with metformin for diabetes management?